News Posts in September, 2021 Sep 30 2021 Ramucirumab combined with Gemcitabine significantly improved overall survival The Lancet Oncology recently published the results of a phase II clinical trial showing Gemcitabine used in line with the antibody Ramucirumab yielded better clinical outcomes for malignant pleural mesothelioma than Gemcitabine used alone. The study ... Continue Reading...